Recent Quotes
My Watchlist
Indicators
Star 60
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Alkermes plc - Ordinary Shares (NQ: ALKS )

29.65 +0.15 (+0.51%)
Streaming Delayed Price Updated: 1:00 PM EST, Dec 24, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 417,111
Open 29.51
Bid (Size) 29.63 (4)
Ask (Size) 29.65 (42)
Prev. Close 29.50
Today's Range 29.26 - 29.75
52wk Range 22.90 - 32.88
Shares Outstanding 166,121,384
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
NASDAQ:ALKS, an undervalued stock with good fundamentals.
ALKERMES PLC (NASDAQ:ALKS): good value for what you're paying. 
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga

Performance

YTD
+3.60%
+3.60%
1 Month
+0.99%
+0.99%
3 Month
+12.18%
+12.18%
6 Month
+20.68%
+20.68%
1 Year
+6.39%
+6.39%

More News

Read More
NASDAQ:ALKS: good value for what you're paying.
Via Chartmill
Charter Communications To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Tuesday
Via Benzinga
A Glimpse Into The Expert Outlook On Alkermes Through 9 Analysts
Via Benzinga
NASDAQ:ALKS is an undervalued gem with solid fundamentals.
Via Chartmill
Alkermes's Earnings: A Preview
Via Benzinga
Decoding 7 Analyst Evaluations For Alkermes
Via Benzinga
Alkermes Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)
Via Benzinga
Alkermes Stock Jumps Nearly 30% In 3 Months Amid Hefty Profits
Via Investor's Business Daily
Despite its impressive fundamentals, NASDAQ:ALKS remains undervalued.
Via Chartmill
NASDAQ:ALKS: good value for what you're paying.
Via Chartmill
Despite its impressive fundamentals, NASDAQ:ALKS remains undervalued.
Via Chartmill
NASDAQ:ALKS stands out as a stock that provides good value for the fundamentals it showcases.
Via Chartmill
ALKS Stock Earnings: Alkermes Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
6 Analysts Assess Alkermes: What You Need To Know
Via Benzinga
The Analyst Landscape: 7 Takes On Alkermes
Via Benzinga
6 Analysts Assess Alkermes: What You Need To Know
Via Benzinga
Why General Dynamics Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
AT&T, Group 1 Automotive, Mattel, Seagate And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
"Rule Breaker Investing" Stock Pick Review: The Big One
Via The Motley Fool
NASDAQ:ALKS is an undervalued gem with solid fundamentals.
Via Chartmill
When you look at NASDAQ:ALKS, it's hard to ignore the strong fundamentals, especially considering its likely undervaluation.
Via Chartmill
In a market where value is scarce, NASDAQ:ALKS offers a refreshing opportunity with its solid fundamentals.
Via Chartmill
3 Biotech Stocks That Could Be Millionaire-Makers: May Edition
Via InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.